AAII ETF Evaluator

ETF Evaluator: Global X HealthTech ETF () Follow This ETF

Equity
Global Asset Class
Sector Equity
Fund Group
Health
Category
$29.705
Last Trade
(as of Aug 26)
$ 28 Mil
Share Class Assets
0.27%
TTM Yield
$33.590 - $23.000
52-Wk High-Low Range
0.50% C
Expense Ratio
60%
Portfolio Turnover
8 (k)
Avg. Daily Trading Vol.
Data as of 7/31/2026
-3.2% F (NAV)
-2.5% D (Price)
1-Mo Return
6.2% F (NAV)
6.6% F (Price)
3-Mo Return
-8.4% F (NAV)
-7.9% F (Price)
YTD Return
-13.7% F (NAV)
-13.7% F (Price)
1-Yr Return
-9.3% F (NAV)
-9.1% F (Price)
3-Yr Return
-13.4% F (NAV)
-13.4% F (Price)
5-Yr Return
1.25 F
Category
Risk
Index
2.04
Total
Risk
Index

ETF Details

Fund Family
Global X Funds

Inception Date
7/29/2020

Website

Phone
888-493-8631

Primary Benchmark
MSCI ACWI NR USD: 100%

Secondary Benchmark
Global X HealthTech Net TR USD: 100%

Additional Fund Details

Global X HealthTech ETF Overview

Global X HealthTech ETF (HEAL) is a passively managed Sector Equity Health exchange-traded fund (ETF). Global X Funds launched the ETF in 2020.

The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Global X HealthTech Index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of healthcare technology and the applications thereof, as determined by the index administrator. The principal investment strategy of the fund will be to invest at least 80% of its total assets, plus borrowings for investment purposes (if any), in the securities of the underlying index. The fund is non-diversified.

About Global X HealthTech ETF (HEAL)

There are 2 members of the management team with an average tenure of 6.01 years: Nam To (2020) and Wayne Xie (2020). Management tenure is more important for actively managed ETFs than passive index ETFs.

The ETF has 2 primary benchmarks: MSCI ACWI NR USD index with a weighting of 100% and Global X HealthTech Net TR USD index with a weighting of 100%. Global X HealthTech ETF has 41 securities in its portfolio. The top 10 holdings constitute 47.1% of the ETF’s assets. The ETF meets the SEC requirement of being classified as a nondiversified fund. The ETF is not considered to have an ESG focus with its investment selection and management.

Global X HealthTech ETF is part of the Equity global asset class and is within the Sector Equity ETF group. Global X HealthTech ETF has 17.1% of its portfolio invested in foreign issues. The overall assets allocated to domestic stock is 82.9% There is 17.1% allocated to foreign stock, and 0.0% is allocated to preferred stocks. The bond allocation as a percentage of total assets is 0.0% (0.0% domestic bond, 0.0% foreign bond and 0.0% convertible bond). Global X HealthTech ETF has 0.0% of the portfolio in cash.

Assets Under Management

The fund has $28 million in total assets, which is below the $1 billion average for the Health category. Normally, lower assets under management translates to higher average expense ratios, and greater total assets are desired. However, for some investment categories, such as small-cap investing, it may be difficult for the manager to fully employ the desired active strategy if assets grow too large or too quickly.

HEAL Performance and Fees

The expense ratio measures how much of a fund’s assets are used for administrative expenses and operating expenses, including adviser fees and fees for the transfer agent and custodial services. The Global X HealthTech ETF expense ratio is average compared to funds in the Health category. Global X HealthTech ETF has an expense ratio of 0.50%, which is 3% lower than its category average, making the fund expense ratio grade a C. While it is difficult to predict returns, it is known that high annual expense ratios reduce your rate of return, and excessive fees are difficult to overcome. Active management normally comes with higher expense ratios than passive index management. Certain investment categories such as small company and foreign also normally have higher expense ratios. It is best to compare fund expense ratios against the category averages for meaningful assessments.

High portfolio turnover can translate to higher expenses and lower aftertax returns. Global X HealthTech ETF has a portfolio turnover rate of 59%, which indicates that it holds its assets around / 0.0 years. By way of comparison, the average portfolio turnover is 45% for the Health category.

Recently, in the month of July 2026, Global X HealthTech ETF returned -3.2%, which earned it a grade of F, as the Health category had an average return of -0.1%. The letter grades of A, B, C, D and F are based upon relative rankings within the investment category. A grade of A, for example, would indicate that the return is in the highest 20% for that time period compared to all ETFs in that category.

Global X HealthTech ETF has a trailing yield of 0.27%, which is below the 1.10% category average. The fund normally distributes its income semi-annually.

It’s natural to seek the best-performing investments, but you must consider the relationship between risk and return and the impact of costs and taxes on your realized returns.

Global X HealthTech ETF Grades

Year to date, the ETF has returned -8.4%, 18.1 percentage points worse than the category, which translates into a grade of F. The fund has returned -13.7% over the past year (grade of F), -9.3% over the past three years (grade of F) and -13.4% per year over the past five years (grade of F).

For more ETF grades, analysis and screening tools to help your investment discovery, join AAII for a $2, full-access trial. Learn more here: https://invest.aaii.com/membership.

Otherwise, for more information about Global X HealthTech ETF, including its riskiness, submit your email to unlock the rest of the article.


HEAL Trailing NAV Total Returns Data as of 7/31/26

Last
Month
Last
Quarter
Ann'l.
1Yr
Ann'l.
3Yr
Ann'l.
5Yr
Ann'l.
10Yr
HEAL Return (NAV) -3.2% 6.2% -13.7% -9.3% -13.4% na
HEAL Return (Price) -2.5% 6.6% -13.7% -9.1% -13.4% na
NAV +/- Price Return -0.703% -0.460% 0.025% -0.188% -0.031% na
Health Avg -0.1% 11.2% 36.9% 9.9% 1.6% 8.7%
HEAL Grade (NAV) F F F F F na
+/- Category (NAV) -3.1% -5.1% -50.6% -19.2% -15.0% na
HEAL Tax-Cost Ratio na na 0.1% 0.0% 0.0% na

HEAL Annual NAV Total ReturnsData as of 7/31/26

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
HEAL Return (NAV) -8.4% -1.0% -2.7% -13.0% -29.4% -14.2% na na na na na
HEAL Return (Price) -7.9% -0.6% -2.9% -12.6% -30.0% -14.2% na na na na na
NAV +/- Price Ret -0.056% -0.383% 0.078% -0.031% 0.019% 0.004% na na na na na
Health Avg 9.7% 21.8% 0.1% 2.2% -16.3% 4.3% 30.5% 25.4% -1.5% 26.5% -10.2%
HEAL Grade (NAV) F F D F F F na na na na na
+/- Category -18.1% -22.8% -2.7% -15.2% -13.1% -18.4% na na na na na
Risk Measures
Beta: 1.47
R-Squared: 55%
Standard Deviation: 25.1%
Category Risk Index: 1.25
Category Risk Rating: High
Total Risk Index: 2.04
Total Risk Rating: High
Portfolio Characteristics
Yield: 0.3%
Total Assets: $ 28 Mil
Share Class Assets: $ 28 Mil
Turnover: 59.7%
Expense Ratio: 0.50%
Index Fund: Yes
Index Tracked: MSCI ACWI NR USD
Index Weighting: 100%
Leveraged: No
Socially Responsible Fund: No
Capital Gains Distribution Frequency:
Income Distribution Frequency: Semi-Annually

Management Team

Number of Managers: 2
Longest Tenure: 6.0 years
Average Tenure: 6.0 years
Managers (Year): To Nam (2020), Xie Wayne (2020)

Portfolio Composition (as of 7/31/26)

# of Holdings: 41
% in Top 10 Holdings: 47.1%
Fund is Non-Diversified: Yes
% in Foreign Issues: 17.1%
 

Portfolio Allocation

Domestic Stock: 82.9%
Foreign Stock: 17.1%
Preferred Stock: 0.0%
Domestic Bond: 0.0%
Foreign Bond: 0.0%
Convertible Bond: 0.0%
Other: 0.0%
Cash: 0.0%

Purchase Information

Legal Structure: Open Ended Investment Company
Fund Family: Global X Funds
Phone Number: 888-493-8631
Website: www.globalxfunds.com
Inception Date: July 29, 2020

Expenses and Fees

Expense Ratio (%): 0.50% (Rating: Avg)
Category Average Expense Ratio (%): 0.52%
Copyright 2026 American Association of Individual Investors and Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.